Barclays’s BrightSpring Health Services BTSG Stock Holding History

Barclays’s Portfolio BTSG Stock Details BTSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.07M	Sell	48,685 -149,801	-75%	-$6.03M	﹤0.01%	2340
2025 Q4	$7.43M	Sell	198,486 -222,978	-53%	-$7.48M	﹤0.01%	1912
2025 Q3	$12.5M	Buy	421,464 +214,111	+103%	+$4.98M	﹤0.01%	1516
2025 Q2	$4.89M	Buy	207,353 +131,353	+173%	+$2.74M	﹤0.01%	2157
2025 Q1	$1.37M	Sell	76,000 -45,251	-37%	-$888K	﹤0.01%	2919
2024 Q4	$2.06M	Sell	121,251 -272,474	-69%	-$4.71M	﹤0.01%	2849
2024 Q3	$5.78M	Buy	393,725 +71,633	+22%	+$898K	﹤0.01%	1967
2024 Q2	$3.66M	Buy	322,092 +30,733	+11%	+$336K	﹤0.01%	1727
2024 Q1	$3.17M	Buy	+291,359	New	+$2.91M	﹤0.01%	2177

Other funds holding BTSG

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Barclays's BTSG Position: Q1 2026 in Review

Barclays reduced its BrightSpring Health Services (BTSG) stake by 75% in Q1 2026, selling an estimated $6.03M and leaving 48,685 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2340.

Barclays first reported a position in BTSG in Q1 2024 and has held it in 9 quarters since. The position peaked at $12.5M in Q3 2025. 335 funds tracked by Wall St. Rank hold BTSG as of Q1 2026.

Barclays held 48,685 shares of BrightSpring Health Services worth $2.07M as of Q1 2026.
Barclays sold 149,801 BrightSpring Health Services shares in Q1 2026, an estimated $6.03M.
BrightSpring Health Services made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2340 holding.
Barclays first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 9 quarters since.
Barclays's BrightSpring Health Services position peaked at $12.5M in Q3 2025.
335 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.